Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Stejbach Mark Create: Alert

All | News | Filings
Date FiledTypeDescription
11/19/2021 4 Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Disposed/sold 12,631 shares @ $8.5, valued at $107.4k
Disposed/sold 25,000 options to buy @ $15.87, valued at $396.8k
Disposed/sold 12,500 options to buy @ $20.16, valued at $252k
Disposed/sold 12,500 options to buy @ $28.14, valued at $351.8k
Disposed/sold 12,500 options to buy @ $11.74, valued at $146.8k
Disposed/sold 7,000 options to buy @ $11.88, valued at $83.2k
Disposed/sold 7,000 options to buy @ $9.22, valued at $64.5k
06/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2020 4 Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Granted 4,500 shares @ $0
Granted 7,000 options to buy @ $11.88, valued at $83.2k
05/27/2020 4 Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Bought 2,051 shares @ $9.75, valued at $20k
06/21/2019 4 Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Granted 12,500 options to buy @ $11.74, valued at $146.8k
06/21/2018 4 Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Granted 12,500 options to buy @ $28.14, valued at $351.8k
03/05/2018 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
Txns: Paid exercise price by delivering 2,334 shares @ $57.41, valued at $134k
Paid exercise price by delivering 1,251 shares @ $60.05, valued at $75.1k
Exercised 5,250 options to buy @ $0
Exercised 2,813 options to buy @ $0
02/28/2018 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
Txns: Gifted 1,000 shares @ $0
Paid exercise price by delivering 1,167 shares @ $58.12, valued at $67.8k
Exercised 2,625 options to buy @ $0
02/21/2018 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
Txns: Sold 10,880 shares @ $70.5048, valued at $767.1k
Paid exercise price by delivering 884 shares @ $67.26, valued at $59.5k
Exercised 10,880 options to buy @ $17.3, valued at $188.2k
Granted 54,500 options to buy @ $67.26, valued at $3.7M
Granted 13,500 options to buy @ $0
Exercised 3,000 options to buy @ $0
07/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/08/2017 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
Txns: Sold 10,000 shares @ $60.3352, valued at $603.4k
Exercised 10,000 options to buy @ $17.3, valued at $173k
05/30/2017 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
Txns: Exercised 2,500 options to buy @ $0
03/06/2017 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
03/02/2017 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
02/27/2017 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
02/21/2017 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
01/10/2017 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
01/06/2017 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
11/14/2016 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
10/06/2016 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
09/14/2016 4 Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc
Txns: Granted 25,000 options to buy @ $15.87, valued at $396.8k
09/14/2016 3 Stejbach Mark (Director) has filed a Form 3 on Flexion Therapeutics Inc
06/01/2016 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
Txns: Exercised 2,500 options to buy @ $0
03/04/2016 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
Txns: Exercised 2,813 options to buy @ $0
03/01/2016 4 Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.
Txns: Paid exercise price by delivering 852 shares @ $33.61, valued at $28.6k
Exercised 2,625 options to buy @ $0
Granted 85,000 options to buy @ $32.27, valued at $2.7M
Granted 21,000 options to buy @ $0
12/28/2015 4 Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.
Txns: Sold 10,000 shares @ $80.2392, valued at $802.4k
Exercised 10,000 options to buy @ $17.3, valued at $173k
12/02/2015 4 Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.
Txns: Sold 15,200 shares @ $71.9943, valued at $1.1M
Sold 2,300 shares @ $73.0891, valued at $168.1k
Sold 500 shares @ $73.582, valued at $36.8k
Exercised 18,000 options to buy @ $17.3, valued at $311.4k
11/12/2015 4 Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.
Txns: Gifted 400 shares @ $0
11/04/2015 4 Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.
Txns: Sold 15,670 shares @ $71.9993, valued at $1.1M
Sold 2,330 shares @ $72.5062, valued at $168.9k
Exercised 18,000 options to buy @ $17.3, valued at $311.4k
10/07/2015 4 Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.
Txns: Granted 5,000 shares @ $0
Paid exercise price by delivering 1,676 shares @ $59.77, valued at $100.2k
Granted 5,000 options to buy @ $0
05/29/2015 4 Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.
Txns: Paid exercise price by delivering 813 shares @ $59.92, valued at $48.7k
Exercised 2,500 options to buy @ $0
04/17/2015 4 Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.
Txns: Paid exercise price by delivering 1,591 shares @ $62.83, valued at $100k
Exercised 5,780 options to buy @ $17.3, valued at $100k
03/05/2015 4 Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.
Txns: Paid exercise price by delivering 914 shares @ $72.8, valued at $66.5k
Exercised 2,812 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy